W. Michael Scheld, MD, is the Bayer-Gerald Mandell Professor of Infectious Diseases, Professor of Medicine, Clinical Professor of Neurosurgery, and Director of the Center for Global Health at the University of Virginia School of Medicine. Dr. Scheld's research includes the molecular pathogenesis and pathophysiology of bacterial infections, anti-inflammatory mechanisms of adenosine receptor subtype agonists and antagonists, antimicrobial resistance, sepsis and septic shock, anthrax, and international health issues including HIV/AIDS in Africa.
James M. Hughes, MD, is Professor of Medecine and Public Health with joint appointments in the School of Medicine (Infectious Diseases) and the Rollins School of Public Health (Global Health) at Emory University and Co-Director of the Emory Antibiotic Resistance Center. Dr. Hughes' research includes emerging and reemerging infectious diseases ; antimicrobial resistance ; healthcare-associated infections ; vectorborne and zoonotic diseases ; foodborne and waterborne diseases ; vaccine-preventable diseases ; rapid detection of and response to infectious diseases and bioterrorism ; and strategies for strengthening public health rapacity at the local, national, and global levels.
Richard J. Whitley, MD, is a Distinguished Professor of Pediatrics, Professor of Microbiology, Medicine and Neurosurgery ; Loeb Eminent Scholar Chair in Pediatrics ; Co-Director, Division of Pediatric Infectious Diseases ; Vice-Chair, Department of Pediatrics ; Cancer Research and Training Center ; Faculty, Gene Therapy Center, and Associate Director for Drug Discovery, Comprehensive Cancer Center at the University of Alabama at Birmingham School of Medicine.
He is also Director, Alabama Drug Discovery Alliance, and is responsible for the National Institute of Allergy and Infectious Disease Collaborative Antiviral Study Group. Dr. Whitley studies the translation of molecular biology to clinical application, particularly the engineering of herpes simplex virus for gene therapy.
James M. Hughes, MD, is Professor of Medecine and Public Health with joint appointments in the School of Medicine (Infectious Diseases) and the Rollins School of Public Health (Global Health) at Emory University and Co-Director of the Emory Antibiotic Resistance Center. Dr. Hughes' research includes emerging and reemerging infectious diseases ; antimicrobial resistance ; healthcare-associated infections ; vectorborne and zoonotic diseases ; foodborne and waterborne diseases ; vaccine-preventable diseases ; rapid detection of and response to infectious diseases and bioterrorism ; and strategies for strengthening public health rapacity at the local, national, and global levels.
Richard J. Whitley, MD, is a Distinguished Professor of Pediatrics, Professor of Microbiology, Medicine and Neurosurgery ; Loeb Eminent Scholar Chair in Pediatrics ; Co-Director, Division of Pediatric Infectious Diseases ; Vice-Chair, Department of Pediatrics ; Cancer Research and Training Center ; Faculty, Gene Therapy Center, and Associate Director for Drug Discovery, Comprehensive Cancer Center at the University of Alabama at Birmingham School of Medicine.
He is also Director, Alabama Drug Discovery Alliance, and is responsible for the National Institute of Allergy and Infectious Disease Collaborative Antiviral Study Group. Dr. Whitley studies the translation of molecular biology to clinical application, particularly the engineering of herpes simplex virus for gene therapy.